摘要
存在营养风险的肿瘤患者,只要胃肠道有功能,应首选口服营养补充(oral nutritional supplements,ONS)。ONS可增加营养摄入,维持和改善营养状态,防止体重减轻,增加抗肿瘤治疗耐受性,改善患者临床结局,提高生活质量。肿瘤患者对于ONS制剂的选择,可能受到肿瘤类型和位置及抗肿瘤治疗等因素的影响。为更有效地对肿瘤患者实施规范化经口营养支持治疗,中国营养学会肿瘤营养管理分会组织临床营养专家和肿瘤医学专家,结合最新临床营养指南和研究证据,制定本共识,以期指导临床诊疗,使肿瘤患者获益。
Patients with cancer are often at nutritional risk and the standardized oral nutritional supplements(ONS)is the preferred treatment for those with gastro-enteral function maintained.ONS could increase the nutrition intake,prevent weight loss,improve the tolerance to anti-cancer treatment,and effectively improve the nutritional status,quality of life and clinical outcomes of cancer patients.The choice of ONS may depend on the type,anatomical location and treatment of cancer.To effectively implement standardized oral nutritional support for patients with cancer,the Nutrition Oncology Branch of Chinese Nutrition Society developed evidence-based,concise and practical recommendations based on the latest clinical nutrition guidelines and research evidence.The purpose is to inform clinical practice and benefit patients with cancer.
作者
康军仁
于康
中国营养学会肿瘤营养管理分会
Kang Junren;Yu kang;Nutrition Oncology Branch of Chinese Nutrition Society(Department of Clinical Nutrition,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing100730,China;不详)
出处
《中华临床营养杂志》
CAS
CSCD
北大核心
2024年第5期279-288,共10页
Chinese Journal of Clinical Nutrition
基金
国家重点研发计划项目(2022YFF1100600/2022YFF1100604)。
关键词
肿瘤
营养风险
口服营养补充
特殊医学用途配方食品
肠内营养
Cancer
Nutritional risk
Oral nutritional supplements
Food for special medical purpose
Enteral nutrition
作者简介
通信作者:于康,Email:yuk1997@sina.com。
